Skip to content

Shingles increases Dementia Risk

Scientists caution that contracting shingles may heighten Alzheimer’s risk. An Oxford University-led study suggests the infection triggers a brain reaction tied to dementia by reactivating a dormant herpes virus, typically harmless since childhood. This causes…… Shingles increases Dementia Risk...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Hearing and Loneliness Risks

Researchers have found that hearing loss combined with acute loneliness can accelerate cognitive decline in older adults, offering a potential simple preventive measure for millions at risk of dementia. A University of Geneva study, analyzing…… Hearing and Loneliness Risks...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

200 proteins under investigation

For years, Alzheimer’s research has focused on A-beta and tau amyloids, which harm neurons and impair brain function. A recent study from Johns Hopkins University suggests these plaques may not act alone. Researchers identified over…… 200 proteins under investigation...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Ground-breaking Alzheimers blood test

At the European Academy of Neurology Congress in Helsinki, researchers unveiled a groundbreaking blood test that could revolutionize Alzheimer’s disease management by identifying patients with mild cognitive impairment (MCI) likely to progress rapidly to severe…… Ground-breaking Alzheimers blood test...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Donanemab and Lecanemab rejected for the NHS

Two innovative Alzheimer’s drugs, donanemab and lecanemab, have been rejected by the NHS due to their exorbitant cost and limited impact. These are the first treatments to slow the disease, potentially extending independent living, by…… Donanemab and Lecanemab rejected for the NHS...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here